Pan Dipanjan, Schirra Carsten O, Wickline Samuel A, Lanza Gregory M
Department of Medicine, Washington University School of Medicine, St Louis, MO, 63108, USA.
Contrast Media Mol Imaging. 2014 Jan-Feb;9(1):13-25. doi: 10.1002/cmmi.1571.
Computed tomography (CT) is one of the most frequently pursued radiology technologies applied in the clinics today and in the preclinical field of biomedical imaging. Myriad advances have been made to make this technique more powerful with improved signal sensitivity, rapid image acquisition and faster reconstruction. Synergistic development of novel nanoparticles has been adopted to produce the next-generation CT contrasts agents for imaging specific biological markers. Nanometer-sized agents are anticipated to play a critical part in the prospect of medical diagnostics owing to their capabilities of targeting specific biological markers, extended blood circulation time and defined biological clearance. This review paper introduces the readers to the fundamental design principles of nanoparticulate CT contrast agents with a special emphasis on molecular imaging with noncrystalline high-metal-density nanobeacons.
计算机断层扫描(CT)是当今临床以及生物医学成像临床前领域中最常用的放射技术之一。为了使该技术更强大,在信号灵敏度、快速图像采集和更快重建方面取得了众多进展。已采用新型纳米颗粒的协同开发来生产用于成像特定生物标志物的下一代CT造影剂。由于纳米级造影剂能够靶向特定生物标志物、延长血液循环时间并具有明确的生物清除率,预计它们将在医学诊断前景中发挥关键作用。本文综述向读者介绍了纳米颗粒CT造影剂的基本设计原理,特别强调了使用非晶态高金属密度纳米信标进行分子成像。